# Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome

> **NCT00435487** · PHASE4 · TERMINATED · sponsor: **Pfizer** · enrollment: 173 (actual)

## Conditions studied

- Angina, Unstable
- Myocardial Infarction

## Interventions

- **DRUG:** Dalteparin ( Fragmin)
- **DRUG:** Unfractionated heparin

## Key facts

- **NCT ID:** NCT00435487
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-06
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 173 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2011-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00435487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00435487, "Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00435487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*